Dransay

DrAnsay is a direct-to-consumer wellness brand that sells physician-formulated nutraceuticals, functional beverages, and targeted supplement stacks. Price points sit in the mid-to-premium tier—single SKUs run $35-$60, while 30-day protocols reach $150—and every order ships from the company’s own e-commerce site; no retail distribution is used. The line is built around Dr. A. Ansay’s clinical research on cellular senescence and metabolic flexibility; each capsule or powder pair is patented, third-party tested, and delivered in single-serve, nitrogen-flushed sachets to preserve potency. Flagskus include the NAD+ Precursor Stack and the Fasting-Mimetic Drink Mix, both cited in small human pilot trials the brand funds and publishes. Core buyers are 30-55-year-old professionals who track biomarkers, practice intermittent fasting, and want evidence-based shortcuts to slower aging and sharper cognition; they value transparency, open-source Certificates of Analysis, and the ability to chat with the in-house MD team before purchase. DrAnsay competes with VC-backed supplement startups and legacy pharma-nutrition hybrids, but distances itself by keeping a practicing physician founder on every label, funding its own peer-reviewed studies, and refusing proprietary blends—every milligram is disclosed and traceable to a batch number.